STEP 3 - Home-Study Modules

PART 1 - Protocol Driven-Care in Community Pharmacies: Acute Influenza Treatment

Activity Details
  • Credit Type: Other
  • Credit Amount: 1.00
  • Cost: Free
  • Release: Oct 15, 2018
  • Expires: Oct 14, 2021
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)


Shelley M.  Jones Shelley M. Jones, PharmD, BCPS
Clinical Associate Professor
Department of Emergency Medicine
University of Kentucky College of Pharmacy
Lexington, Kentucky

Needs Statement

New regulations from Board of Pharmacy authorize pharmacists to provide protocol-driven care for influenza. Education and training are required by the Board before pharmacists can implement the new protocols.

Target Audience



Upon completion of this activity, participants will be able to:
1. Discuss pharmacist qualifications for and public health impact on pharmacist‐provided direct patient care
2. Define and describe basic principles of POCT (e.g. sensitivity, specificity, etc.)
3. Describe the pharmacist’s role in POCT
4. Discuss Kentucky regulations and requirements that enable protocol‐driven care
5. Discuss practical applications of implementing protocol‐driven patient care services
6. Explain the process of differential diagnosis and the pharmacist’s application of it in patient care


UK Healthcare CECentral certifies this activity for 1.00 hour of participation.

Faculty Disclosure

No speakers, authors, planners or content reviewers have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


In collaboration with UK College of Pharmacy Experiential Education.

CE Content Concerns


Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504


  • The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
  • If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
  • Issues regarding activity content also will be reviewed and addressed by the Activity Director.
  • A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
  • Grievances will be considered when planning future activities.

Appeal Procedure

  • Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
  • The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
  • The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.